2 completed. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 2 | Completed 2 |
Follow Foundation Fighting Blindness: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of NPI-001 Tablets for RP Associated With Usher Syndrome NPI-001, Placebo - Usher Syndromes | Phase 1 / Phase 2 | Completed | Nacuity Pharmaceuticals, Inc. | 49 | 2020-09-03 | 2026-07-01 |
| An Open Label Clinical Trial of Retinal Gene Therapy for Choroideremia rAAV2.REP1 vector - Choroideremia | Phase 1 / Phase 2 | Completed | University of Alberta | 6 | 2015-04-01 | 2022-05-19 |
Choroideremia (1) · Usher Syndromes (1)
Australia (1) · Canada (1)
Ian M MacDonald, MD, CM (1) · Lee Anderson, MD (1)